621
Views
1
CrossRef citations to date
0
Altmetric
Letter to the Editor

Cachexia therapies – the need to take a broader look

References

  • Molfino A, Amabile M, Rossi Fanelli F, et al. Novel therapeutic options for cachexia and sarcopenia. Expert Opin Biol Ther. 2016;16:1239–1244.
  • Skuk D, Tremblay JP. Cell therapy in muscular dystrophies: many promises in mice and dogs, few facts in patients. Expert Opin Biol Ther. 2015;15(9):1307–1319.
  • Andia I, Abate M. Platelet-rich plasma in the treatment of skeletal muscle injuries. Expert Opin Biol Ther. 2015 Jul;15(7):987–999. DOI:10.1517/14712598.2015.1038234
  • [Cited 2017 Sep 1]. Available from: http://www.apmhealtheurope.com/print_story.php?numero=L1135.
  • Stewart Coats AJ, Ho GF, Prabhash K, et al. Espindolol for the treatment and prevention of cachexia in patients with stage III/IV non-small cell lung cancer or colorectal cancer: a randomized, double-blind, placebo-controlled, international multicentre phase II study (the ACT-ONE trial). J Cachexia Sarcopenia Muscle. 2016 Jun;7(3):355–365. DOI:10.1002/jcsm.12126.
  • Lainscak M, Act-One LA. ACTION at last on cancer cachexia by adapting a novel action beta-blocker. J Cachexia Sarcopenia Muscle. 2016 Sep;7(4):400–402. DOI:10.1002/jcsm.12136
  • Ferraro E, Pin F, Gorini S, et al. Improvement of skeletal muscle performance in ageing by the metabolic modulator Trimetazidine. J Cachexia Sarcopenia Muscle. 2016 Sep;7(4):449–457. DOI:10.1002/jcsm.12097
  • Penna F, Bonetto A, Aversa Z, et al. Effect of the specific proteasome inhibitor bortezomib on cancer-related muscle wasting. J Cachexia Sarcopenia Muscle. 2016 Jun;7(3):345–354. DOI:10.1002/jcsm.12050
  • Hatanaka M, Konishi M, Ishida J, et al. Novel mechanism of ghrelin therapy for cachexia. J Cachexia Sarcopenia Muscle. 2015 Dec;6(4):393. DOI:10.1002/jcsm.12084.
  • Konishi M, Pelgrim L, Tschirner A, et al. Febuxostat improves outcome in a rat model of cancer cachexia. J Cachexia Sarcopenia Muscle. 2015 Jun;6(2):174–180. DOI:10.1002/jcsm.12017
  • Sasso JP, Eves ND, Christensen JF, et al. A framework for prescription in exercise-oncology research. J Cachexia Sarcopenia Muscle. 2015 Jun;6(2):115–124. DOI:10.1002/jcsm.12042
  • Grande AJ, Silva V, Maddocks M. Exercise for cancer cachexia in adults: executive summary of a Cochrane Collaboration systematic review. J Cachexia Sarcopenia Muscle. 2015 Sep; 6(3):208–211. DOI:10.1002/jcsm.12055.
  • Drescher C, Konishi M, Ebner N, et al. Loss of muscle mass: current developments in cachexia and sarcopenia focused on biomarkers and treatment. J Cachexia Sarcopenia Muscle. 2015 Dec;6(4):303–311. DOI:10.1002/jcsm.12082.
  • Laviano A, Cachexia: MA. Looking yet not seeing. J Cachexia Sarcopenia Muscle. 2016 Dec;7(5):510–511.
  • Loncar G, Springer J, Anker M, et al. Cardiac cachexia: hic et nunc. J Cachexia Sarcopenia Muscle. 2016 Jun;7(3):246–260. DOI:10.1002/jcsm.12118

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.